Display options
Cite
Sanoff HK, McLeod HL. Predictive Factors for Response and Toxicity in Chemotherapy: Pharmacogenomics. Semin Colon Rectal Surg. 2008;19(4):226-230doi: 10.1053/j.scrs.2008.09.007.
Sanoff, H. K., & McLeod, H. L. (2008). Predictive Factors for Response and Toxicity in Chemotherapy: Pharmacogenomics. Seminars in colon & rectal surgery, 19(4), 226-230. https://doi.org/10.1053/j.scrs.2008.09.007
Sanoff, Hanna K, and McLeod, Howard L. "Predictive Factors for Response and Toxicity in Chemotherapy: Pharmacogenomics." Seminars in colon & rectal surgery vol. 19,4 (2008): 226-230. doi: https://doi.org/10.1053/j.scrs.2008.09.007
Sanoff HK, McLeod HL. Predictive Factors for Response and Toxicity in Chemotherapy: Pharmacogenomics. Semin Colon Rectal Surg. 2008 Dec;19(4):226-230. doi: 10.1053/j.scrs.2008.09.007. PMID: 19956343; PMCID: PMC2614280.
Copy Download .nbib Format: NLM
Share it on

Semin Colon Rectal Surg. 2008 Dec;19(4):226-230. doi: 10.1053/j.scrs.2008.09.007.

Predictive Factors for Response and Toxicity in Chemotherapy: Pharmacogenomics.

Seminars in colon & rectal surgery

Hanna K Sanoff, Howard L McLeod

Affiliations

  1. Department of Medicine, Division of Hematology Oncology, University of North Carolina, Chapel Hill, NC, USA.

PMID: 19956343 PMCID: PMC2614280 DOI: 10.1053/j.scrs.2008.09.007

[No abstract available.]

References

  1. Pharmacogenomics J. 2001;1(1):65-70 - PubMed
  2. J Clin Oncol. 2000 Aug;18(16):2938-47 - PubMed
  3. J Clin Oncol. 1997 Oct;15(10):3223-9 - PubMed
  4. N Engl J Med. 1985 Jul 25;313(4):245-9 - PubMed
  5. J Clin Oncol. 1996 Jan;14(1):176-82 - PubMed
  6. Pharmacogenetics. 1994 Dec;4(6):301-6 - PubMed
  7. Cancer Res. 1995 Apr 1;55(7):1407-12 - PubMed
  8. Clin Cancer Res. 1996 Mar;2(3):477-81 - PubMed
  9. BMJ. 2000 Sep 2;321(7260):531-5 - PubMed
  10. N Engl J Med. 2000 Sep 28;343(13):905-14 - PubMed
  11. J Clin Oncol. 2001 Sep 15;19(18):3801-7 - PubMed
  12. Pharmacogenetics. 2002 Oct;12(7):555-8 - PubMed
  13. J Clin Oncol. 2007 Aug 10;25(23):3456-61 - PubMed
  14. Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8699-705 - PubMed
  15. Eur J Cancer. 2007 Apr;43(6):1011-6 - PubMed
  16. J Clin Invest. 1988 Jan;81(1):47-51 - PubMed
  17. Pharmacogenomics J. 2002;2(1):43-7 - PubMed
  18. J Clin Oncol. 2004 Jan 1;22(1):23-30 - PubMed
  19. Lancet. 2008 Mar 22;371(9617):1007-16 - PubMed
  20. Int J Cancer. 2002 Sep 20;101(3):253-8 - PubMed
  21. Anticancer Res. 1999 Jul-Aug;19(4B):3249-52 - PubMed
  22. J Clin Oncol. 2007 Oct 20;25(30):4779-86 - PubMed
  23. J Natl Cancer Inst. 2007 Sep 5;99(17):1290-5 - PubMed
  24. J Clin Invest. 1996 Aug 1;98(3):610-5 - PubMed
  25. Cancer Res. 2000 Dec 15;60(24):6921-6 - PubMed
  26. N Engl J Med. 2004 Jun 3;350(23):2343-51 - PubMed
  27. J Clin Oncol. 2004 May 15;22(10):1797-806 - PubMed
  28. Cancer Res. 1987 Apr 15;47(8):2203-6 - PubMed
  29. J Clin Oncol. 2004 Apr 15;22(8):1382-8 - PubMed
  30. Br J Cancer. 2004 Aug 16;91(4):678-82 - PubMed
  31. Br J Clin Pharmacol. 2007 Aug;64(2):237-40 - PubMed
  32. Clin Cancer Res. 2004 Aug 1;10(15):5151-9 - PubMed

Publication Types

Grant support